FTISADTSK-13C6,15N2 (TFA) is a high-purity isotopically labeled peptide used in advanced pharmaceutical and biochemical research. This compound, labeled with carbon-13 and nitrogen-15 isotopes, is crucial for studies involving protein structure, metabolic pathways, and quantitative proteomics. The trifluoroacetic acid (TFA) salt form ensures enhanced solubility and stability. With precise isotopic labeling, it provides reliable analytical results. Ideal for mass spectrometry and protein research, FTISADTSK-13C6,15N2 (TFA) integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.
| Catalog Number | S000098 |
| Molecular Formula | C3813C6H69F3N815N2O18 |
| Purity | 95% |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-220. [2]. Bults P, et al. LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma. Anal Chem. 2016;88(3):1871-1877. |
.gif)